Browse by Category - HHS Grants Forecast

STATUS

FORECASTED - Last Updated on 01/15/2013

Cooperative Agreement for the Physician Clinical Support System - Medication Assisted Treatment (PCSS-MAT)

Most Recent Update:

01/15/2013 10:48:52 AM

denotes Help Information

Summary:

Funding Opportunity Number:

TI-13-003

Forecast ID Number:

SAMHSA-2013-FCAST-0009

Fiscal Year:

2013

Funding Opportunity Title:

Cooperative Agreement for the Physician Clinical Support System - Medication Assisted Treatment (PCSS-MAT)

CFDA Number:

93.243

Funding Activity Category:

Health (HL)

CFDA Number Description:

Alcoholism, Drug Abuse, and Mental Health_General
Alcoholism, Drug Abuse, and Mental Health_Planning
Alcoholism, Drug Abuse, and Mental Health_Research
Mental Health Services

Funding Instrument Type Code(s):

Cooperative Agreement

Cost Sharing / Matching Requirement:

Recovery Act:

Affordable Care Act (ACA):

Estimated Funding Information:

Estimated Funding:

$1,000,000

Expected Number of Awards:

Estimated Award Ceiling:

$1,000,000

Estimated Award Floor:

Estimated Milestone Dates:

Estimated Post Date:

02/01/2013

Estimated Application Due Date:

04/01/2013

Estimated Award Date:

07/08/2013

Estimated Start Date:

09/30/2013

Eligibility:

Eligibility Category:

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Eligibility Information:

Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of physicians desiring to prescribe and/or dispense FDA approved buprenorphine, vivitrol, and extended release vivitrol products for the treatment of addictive disorders. These are the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, and the American Psychiatric Association. Any of these entities may apply individually; they may also apply as a consortium comprised of all or several of the eligible organizations. If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium submits an application, the application must include a written agreement outlining the roles and responsibilities of each participating national professional medical organization. This agreement must be signed by an authorized official of each member of the consortium and attached to the application in Attachment 3 Roles and Responsibilities of Participating National Professional Medical Organizations.

Description:

The purpose of this program is to expand upon the current SAMHSA-funded Physician Clinical Support System - Buprenorphine (PCSS-B) by increasing the amount of training for office-based physicians and opioid treatment program professionals. The program will provide evidence-based training and up to date treatment modalities surrounding complex issues of addiction. By enlisting the assistance of addiction medicine and psychiatry medical specialty organizations and other organizations that focus on opioid addiction, medication assisted treatment, and recovery from opioid addiction, the grantee will offer physicians, substance abuse specialists, and other health professions the information and consultation they need to provide safe, appropriate, and effective pharmacologic treatment for opioid dependence, thereby reducing resistance and barriers to the availability of treatment. The grantee will address medical and psychiatric co-morbidities that are highly prevalent in those with addictive disorders and which contribute to the complex nature of opioid addiction.

Federal Agency Contact Information:

Federal Agency:

Department of Health and Human Services

Name:

Anthony Campbell

Email Address:

anthony.campbell@samhsa.hhs.gov

Phone:

240-276-2702

OpDiv:

Substance Abuse & Mental Health Services Administration

Sub OpDiv:

Center for Substance Abuse Treatment

<< Back to Search Results